July 30th 2025
Haller expands her leadership role of ophthalmologist-in-chief following the retirement of longtime executive Joseph P. Bilson.
AAO 2024: New study shows promise for MICE procedure in treating corneal neovascularization
October 22nd 2024Kamran Riaz, MD, discussed with the Eye Care Network a study on mitomycin intravascular chemoembolization for treating corneal neovascularization. The procedure showed promise, with a 70% success rate at 3 to 6 months, though patient selection is crucial. Some required multiple treatments, but overall outcomes are promising.
Watch
Harrow relaunches triamcinolone acetonide injectable suspension
October 3rd 2024Marketed as Triesence, it is a preservative free synthetic corticosteroid that is approved by the FDA for visualization during vitrectomy and for the treatment of ocular inflammatory conditions that are unresponsive to topical corticosteroids.
Read More
Eye surgery showcase goes to Australian Parliament House
August 13th 2024The Australian Society of Ophthalmologists hosted its inaugural Eye Surgery Showcase, where participants learned how ophthalmologists and the medical technology industry are working together to save the sight of Australians.
Read More
Loyola Medicine ophthalmologists travel to Guatemala to provide advanced eye care
August 4th 2024A team of 14 eyecare professionals made the recent trip including faculty from the Loyola Medicine Department of Ophthalmology and faculty and residents from Cook County Health, Northwestern Medicine, Wills Eye Hospital in Philadelphia, the University of Toledo College of Medicine and Champlain Ophthalmology in Bethesda, Maryland.
Read More